Annual EPS
-$1.39
+$1.21+46.54%
31 December 2023
Summary:
Protagonist Therapeutics annual earnings per share is currently -$1.39, with the most recent change of +$1.21 (+46.54%) on 31 December 2023. During the last 3 years, it has risen by +$1.32 (+48.71%). PTGX annual EPS is now at all-time high.PTGX EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$0.54
-$0.04-8.00%
30 September 2024
Summary:
Protagonist Therapeutics quarterly earnings per share is currently -$0.54, with the most recent change of -$0.04 (-8.00%) on 30 September 2024. Over the past year, it has dropped by -$0.98 (-222.73%). PTGX quarterly EPS is now -116.56% below its all-time high of $3.26, reached on 31 March 2024.PTGX Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
$2.66
+$0.04+1.53%
30 September 2024
Summary:
Protagonist Therapeutics TTM earnings per share is currently $2.66, with the most recent change of +$0.04 (+1.53%) on 30 September 2024. Over the past year, it has increased by +$4.15 (+278.52%). PTGX TTM EPS is now at all-time high.PTGX TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -222.7% | +278.5% |
| 3 y3 years | +48.7% | +29.9% | +198.5% |
| 5 y5 years | +53.4% | +14.3% | +188.7% |
PTGX EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +48.7% | -116.6% | +35.7% | at high | +193.7% |
| 5 y | 5 years | at high | +53.4% | -116.6% | +35.7% | at high | +184.7% |
| alltime | all time | at high | +76.0% | -116.6% | +73.0% | at high | +162.4% |
Protagonist Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$0.54(+8.0%) | $2.66(+1.5%) |
| June 2024 | - | -$0.50(-115.3%) | $2.62(+7.4%) |
| Mar 2024 | - | $3.26(+640.9%) | $2.44(-263.8%) |
| Dec 2023 | -$1.39(-46.5%) | $0.44(-175.9%) | -$1.49(-43.1%) |
| Sept 2023 | - | -$0.58(-14.7%) | -$2.62(-2.2%) |
| June 2023 | - | -$0.68(+1.5%) | -$2.68(-5.6%) |
| Mar 2023 | - | -$0.67(-2.9%) | -$2.84(+9.2%) |
| Dec 2022 | -$2.60(-4.1%) | -$0.69(+7.8%) | -$2.60(-3.0%) |
| Sept 2022 | - | -$0.64(-23.8%) | -$2.68(-2.2%) |
| June 2022 | - | -$0.84(+95.3%) | -$2.74(+5.8%) |
| Mar 2022 | - | -$0.43(-44.2%) | -$2.59(-4.1%) |
| Dec 2021 | -$2.71(+41.1%) | -$0.77(+10.0%) | -$2.70(+12.0%) |
| Sept 2021 | - | -$0.70(+1.4%) | -$2.41(+25.5%) |
| June 2021 | - | -$0.69(+27.8%) | -$1.92(+5.5%) |
| Mar 2021 | - | -$0.54(+12.5%) | -$1.82(-9.0%) |
| Dec 2020 | -$1.92(-35.6%) | -$0.48(+128.6%) | -$2.00(-7.0%) |
| Sept 2020 | - | -$0.21(-64.4%) | -$2.15(-15.7%) |
| June 2020 | - | -$0.59(-18.1%) | -$2.55(-18.8%) |
| Mar 2020 | - | -$0.72(+14.3%) | -$3.14(+4.7%) |
| Dec 2019 | -$2.98 | -$0.63(+3.3%) | -$3.00(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$0.61(-48.3%) | -$2.94(+8.5%) |
| June 2019 | - | -$1.18(+103.4%) | -$2.71(+39.7%) |
| Mar 2019 | - | -$0.58(+1.8%) | -$1.94(+12.8%) |
| Dec 2018 | -$1.74(-16.7%) | -$0.57(+50.0%) | -$1.72(+32.3%) |
| Sept 2018 | - | -$0.38(-7.3%) | -$1.30(+7.4%) |
| June 2018 | - | -$0.41(+13.9%) | -$1.21(-28.4%) |
| Mar 2018 | - | -$0.36(+140.0%) | -$1.69(-22.1%) |
| Dec 2017 | -$2.09(-64.0%) | -$0.15(-48.3%) | -$2.17(-19.3%) |
| Sept 2017 | - | -$0.29(-67.4%) | -$2.69(-17.7%) |
| June 2017 | - | -$0.89(+6.0%) | -$3.27(+15.6%) |
| Mar 2017 | - | -$0.84(+25.4%) | -$2.83(-29.1%) |
| Dec 2016 | -$5.80(+128.6%) | -$0.67(-23.0%) | -$3.99(-6.3%) |
| Sept 2016 | - | -$0.87(+93.9%) | -$4.26(+7.0%) |
| June 2016 | - | -$0.45(-77.6%) | -$3.98(-2.4%) |
| Mar 2016 | - | -$2.00(+113.1%) | -$4.08(+60.9%) |
| Dec 2015 | -$2.54(+33.1%) | -$0.94(+58.7%) | -$2.54(+58.8%) |
| Sept 2015 | - | -$0.59(+8.3%) | -$1.60(+58.9%) |
| June 2015 | - | -$0.55(+19.4%) | -$1.01(+119.4%) |
| Mar 2015 | - | -$0.46 | -$0.46 |
| Dec 2014 | -$1.91 | - | - |
FAQ
- What is Protagonist Therapeutics annual earnings per share?
- What is the all time high annual EPS for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly EPS year-on-year change?
- What is Protagonist Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Protagonist Therapeutics?
- What is Protagonist Therapeutics TTM EPS year-on-year change?
What is Protagonist Therapeutics annual earnings per share?
The current annual EPS of PTGX is -$1.39
What is the all time high annual EPS for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual earnings per share is -$1.39
What is Protagonist Therapeutics quarterly earnings per share?
The current quarterly EPS of PTGX is -$0.54
What is the all time high quarterly EPS for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly earnings per share is $3.26
What is Protagonist Therapeutics quarterly EPS year-on-year change?
Over the past year, PTGX quarterly earnings per share has changed by -$0.98 (-222.73%)
What is Protagonist Therapeutics TTM earnings per share?
The current TTM EPS of PTGX is $2.66
What is the all time high TTM EPS for Protagonist Therapeutics?
Protagonist Therapeutics all-time high TTM earnings per share is $2.66
What is Protagonist Therapeutics TTM EPS year-on-year change?
Over the past year, PTGX TTM earnings per share has changed by +$4.15 (+278.52%)